The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

Image: Ralph Losey using AI. EDRM Editor’s Note: EDRM is proud to publish Ralph Losey’s advocacy and analysis. The opinions and positions are Ralph Losey’s copyrighted work. All images in the article ...

Choose from one of two sub-specialties in our program: our adult track, or our child and family track (you may choose to specialize in pediatric psychology within the latter). You can complete either ...

In analyzed electronic health records, Black patients were more likely than white patients to have notes from clinicians undermining their credibility. While such language appeared in less than 1% of ...

As researchers unlock the diagnostic and therapeutic promise of the human microbiome, a new roadmap highlights the urgent need for standardization, better evidence, and clinician education to ...

New York-based White Plains Hospital is collaborating with Layer Health, an AI-enabled chart review company, to automate reporting across multiple clinical registries and accelerate the chart review ...

Stella Osoba is the Senior Editor of trading and investing at Investopedia. She co-founded and chaired Women in Technical Analysis. She has 15+ years of experience as a financial writer and technical ...

When I worked on the shop floor, my supervisor asked if I wanted to spend time in production control developing a better way to improve workflow throughout the department. I wanted to move into ...

Blood sugar management is crucial for people with diabetes, but target levels vary based on individual factors, not just age. While there are general guidelines for blood sugar levels based on age ...

New evidence–based clinical practice guidelines from the Alzheimer’s Association provide updated recommendations on evaluating individuals suspected of having Alzheimer’s disease (AD) and AD-related ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to boost its kidney disease candidates further by going public. The Bay ...